Status Conference Held in Tylenol liver injury litigation

A status conference was held on June 17, 2014 in the Tylenol multi-district litigation pending in the United States District Court, Eastern Division of Pennsylvania.

According to court documents, more than 140 lawsuits have been filed In Re: Tylenol Marketing, Sales Practices and Products Liability Litigation, MDL No. 2436. The lawsuits allege that Johnson & Johnson and McNeil Consumer Healthcare failed to provide sufficient warnings of the possibility of liver damage from use of acetaminophen. Many of the suits claim that acetaminophen caused liver damage even when the drug was used according to the usage label.

Acetaminophen is the active ingredient in numerous over-the-counter medications. Tylenol brand products are the most popular acetaminophen products on the market. Tylenol is marketed by Johnson & Johnson and McNeil Consumer Healthcare.

Acetaminophen has been linked to liver damage and liver failure and is believed to be responsible for over 30,000 hospital admissions and 78,000 emergency room treatments every year. The most serious cases of acetaminophen injury can result in the need for a liver transplant or death.

The Ohio Tylenol injury attorneys at Clark, Perdue & List are investigating claims of liver damage and liver failure resulting from acetaminophen. If you or a loved one has suffered liver damage that resulted in hospitalization or the need for a liver transplant, you may be entitled to compensation. Contact the pharmaceutical attorneys at Clark, Perdue & List.

Disclaimer: The information provided in this article is for general informational purposes only and does not constitute legal advice. Every case is unique, and laws are subject to change. Reading this article does not create an attorney-client relationship. Please consult with a qualified attorney regarding your specific legal situation.

Share With Your Colleagues